BRIEF published on 05/11/2026 at 09:05, 23 days 1 hour ago NuWays AG Recommends Buy for Aiforia Technologies Oyj NuWays AG Oncology Diagnostics Aiforia Technologies AI Pathology Healthcare M&A
PRESS RELEASE published on 05/11/2026 at 09:00, 23 days 1 hour ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Update on Aiforia Technologies Oyj classification from NuWays AG including strong market catalyst and analysis on AI pathology in the clinical oncology diagnostics field NuWays AG Market Analysis Oncology Diagnostics Aiforia Technologies Oyj AI Pathology
BRIEF published on 04/17/2026 at 09:05, 1 month 16 days ago Aiforia Technologies Secures Exclusive AI Partnership in France AI Diagnostics Aiforia Technologies PROSTIA Project AP-HP Partnership French Healthcare
PRESS RELEASE published on 04/17/2026 at 09:00, 1 month 16 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj selected as sole AI partner for PROSTIA project by Assistance Publique-Hôpitaux de Paris, expanding cancer diagnostics in France. Landmark deployment validates Aiforia's market leadership Cancer Diagnostics France AI Partner Aiforia Technologies Oyj PROSTIA Project
BRIEF published on 03/11/2026 at 09:05, 2 months 23 days ago Aiforia Technologies Oyj Sees Clinical Growth Surge European Market Cash Position Profitability Improvement Client Expansion Clinical Growth
PRESS RELEASE published on 03/11/2026 at 09:00, 2 months 23 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj by NuWays AG analyzed: Clinical growth accelerates, profitability improves with increased share of wallet and workforce reductions. Target price EUR 3.8 Profitability NuWays AG Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 03/09/2026 at 09:05, 2 months 25 days ago Aiforia Technologies Oyj Poised for Growth in Clinical Segment Strategic Partnerships Revenue Expansion EBITDA Improvement Market Share Clinical Growth
PRESS RELEASE published on 03/09/2026 at 09:00, 2 months 25 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj's clinical segment shows strong growth with a clear roadmap for scaling, leading to improved profitability and strategic partnerships. Research recommends buying with a target price of EUR 3.80 Strategic Partnerships Profitability Target Price Aiforia Technologies Oyj Clinical Growth
BRIEF published on 02/27/2026 at 09:05, 3 months 4 days ago Aiforia Technologies Oyj Anticipates Strong Clinical Revenue Growth Strategic Partnerships AI Technology Profitability Financial Growth Clinical Revenue
PRESS RELEASE published on 02/27/2026 at 09:00, 3 months 4 days ago Original-Research: Aiforia Technologies Oyj (von NuWays AG): BUY Aiforia Technologies Oyj's updated research report by NuWays AG reveals accelerated clinical revenue growth expectations, with key focus on AI technology adoption and strategic partnerships for sales growth NuWays AG Research Report Aiforia Technologies Oyj Clinical Revenue Growth AI Technology Adoption
Published on 06/03/2026 at 10:00, 17 minutes ago Eagle Plains and Xcite Define Prospective Geophysical Trends at Beaver River Uranium Project, SK
Published on 06/03/2026 at 09:01, 1 hour 16 minutes ago Apex Announces Drill Program Expansion and H2 Exploration Plans at the Rift Rare Earth Project
Published on 06/03/2026 at 04:58, 5 hours 19 minutes ago Snipp Interactive Reports Q1 2026 Financial Results; Bookings Backlog Reaches Record $20.6 Million; Announces Conference Call on Wednesday, June 3, 2026
Published on 06/03/2026 at 00:00, 10 hours 17 minutes ago Onco-Innovations Advances 1kg Scale-Up of B4 Precursor Supporting ONC010 Manufacturing and Clinical Development Program
Published on 06/03/2026 at 10:05, 12 minutes ago SLOVAKIAN BAR WINS INAUGURAL EUROPE'S 50 BEST BARS MICHTER'S ART OF HOSPITALITY AWARD
Published on 06/03/2026 at 10:00, 17 minutes ago World Bronchiectasis Conference 2026 returns to Hannover: 10 years of progress from neglected disease to global movement
Published on 06/03/2026 at 09:40, 37 minutes ago Medios AG: Contract of Executive Board Member Constantijn van Rietschoten extended ahead of schedule
Published on 06/03/2026 at 09:30, 46 minutes ago LION E-Mobility AG: Ian Mukherjee to assume Role of Chairman of the Board of Directors
Published on 06/03/2026 at 09:30, 47 minutes ago Skyborn Renewables appoints Michael Klingele as Chief Operating Officer
Published on 06/03/2026 at 08:45, 1 hour 32 minutes ago Air Liquide announces milestone investment in South Korea to support SK hynix’s advanced AI memory chip project
Published on 06/02/2026 at 18:03, 16 hours 14 minutes ago Total number of voting rights and shares making up the share capital at May 31, 2026
Published on 06/02/2026 at 17:42, 16 hours 35 minutes ago Aéroports de Paris SA - Shares and voting rights as of 31 May 2026
Published on 06/02/2026 at 17:40, 16 hours 37 minutes ago Campus AI enters the implementation phase: Eiffage selected for deployment of shared infrastructure on the Fouju Campus in a deal worth over €120 million
Published on 06/02/2026 at 08:00, 1 day 2 hours ago EURAZEO’S PRIVATE DEBT FUND CLOSES AT RECORD €3.9 BILLION, EXCEEDING ITS INITIAL TARGET
